Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta‐analysis by geographic region with a focus on European patients-Reference-Cited by-同舟云学术

Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta‐analysis by geographic region with a focus on European patients

Published:2016-06-17 Issue:3 Volume:82 Page:633-644
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Gómez‐Outes Antonio¹,Terleira‐Fernández Ana‐Isabel²³,Calvo‐Rojas Gonzalo⁴,Suárez‐Gea M. Luisa¹,Vargas‐Castrillón Emilio²³

Affiliation:

1. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) Madrid Spain

2. Hospital Clínico San Carlos Madrid Spain

3. Universidad Complutense Madrid Spain

4. Hospital Clinic Barcelona Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13005

Reference39 articles.

1. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

2. Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives

3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

4. Guidance document: global pharmacoeconomic model adaption strategies;Mullins CD;ViHRI,2014

5. Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions;Expert Opinion on Pharmacotherapy;2022-11-22

2. Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-06-30

3. Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trials;Pharmacological Research;2022-01

4. Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry;IJC Heart & Vasculature;2020-12

5. Use of non‐vitamin K antagonist oral anticoagulants in Colombia: A descriptive study using a national administrative healthcare database;Pharmacoepidemiology and Drug Safety;2020-10-15